Wordt geladen...
Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
Doxorubicin (DOX) is metabolized to a variety of metabolites in vivo, which has been shown to be associated with cardiotoxicity. We speculate that metabolic processes are also present in tumor cells. A LC-MS/MS method was developed to detect intracellular metabolites. Drug resistant tumor cells with...
Bewaard in:
| Gepubliceerd in: | Front Pharmacol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6909010/ https://ncbi.nlm.nih.gov/pubmed/31866863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.01434 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|